H. Amarens Geuzinge

MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial

Sepideh Saadatmand, H. Amarens Geuzinge, Emiel J. Rutgers et al. · The Lancet Oncology · 2019 · 168 citations · Full text

Familial Risk, Medical Imaging, Cancer Detection +8

Cost-Effectiveness of Magnetic Resonance Imaging Screening for Women With Extremely Dense Breast Tissue

H. Amarens Geuzinge, Marije F. Bakker, Eveline A.M. Heijnsdijk et al. · JNCI Journal of the National Cancer Institute · 2021 · 82 citations · Full text

Breast Cancer Screening Strategies for Women With <i>ATM, CHEK2</i>, and <i>PALB2</i> Pathogenic Variants

Kathryn P. Lowry, H. Amarens Geuzinge, Natasha K. Stout et al. · JAMA Oncology · 2022 · 82 citations · Full text

Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk

H. Amarens Geuzinge, Inge-Marie Obdeijn, Emiel J. Rutgers et al. · JAMA Oncology · 2020 · 51 citations · Full text

Experiences, expectations and preferences regarding MRI and mammography as breast cancer screening tools in women at familial risk

H. Amarens Geuzinge, Eveline A.M. Heijnsdijk, Inge-Marie Obdeijn et al. · The Breast · 2021 · 16 citations · Full text